331 related articles for article (PubMed ID: 9714974)
1. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
2. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
[TBL] [Abstract][Full Text] [Related]
3. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
4. Treatment of genital warts with an immune-response modifier (imiquimod).
Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod in clinical practice.
Edwards L
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
8. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study.
Syed TA; Goswami J; Ahmadpour OA; Ahmad SA
J Dermatol; 1998 May; 25(5):309-13. PubMed ID: 9640884
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata.
Dede M; Kubar A; Yenen MC; Alanbay I; Guven S; Mesten Z; Baser I
Acta Obstet Gynecol Scand; 2007; 86(8):968-72. PubMed ID: 17653883
[TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
Sauder DN; Skinner RB; Fox TL; Owens ML
Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
[TBL] [Abstract][Full Text] [Related]
11. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
Fife KH; Ferenczy A; Douglas JM; Brown DR; Smith M; Owens ML;
Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
[TBL] [Abstract][Full Text] [Related]
12. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Diamantis ML; Bartlett BL; Tyring SK
Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions].
Gross G
Hautarzt; 2001 Jan; 52(1):6-17. PubMed ID: 11220242
[TBL] [Abstract][Full Text] [Related]
15. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
Carrasco D; vander Straten M; Tyring SK
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
[TBL] [Abstract][Full Text] [Related]
16. Imiqimod in clinical practice.
Trofatter KF
Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod: a cytokine inducer.
Dahl MV
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
[No Abstract] [Full Text] [Related]
18. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.
Arany I; Tyring SK; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
Antiviral Res; 1999 Aug; 43(1):55-63. PubMed ID: 10480263
[TBL] [Abstract][Full Text] [Related]
19. Immune response modification: imiquimod.
Tyring S
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S11-3. PubMed ID: 9842095
[TBL] [Abstract][Full Text] [Related]
20. Effect of imiquimod in anogenital warts from HIV-positive men.
Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]